Valeo Pharma (TSE:VPH) has released an update.
Valeo Pharma Inc., a Canadian pharmaceutical company, has announced a significant leadership transition with Mr. Al Moghaddam appointed as the new CEO, succeeding Steve Saviuk, who will become Chairman of the Board. The company is poised for growth with a solid product portfolio and plans for expansion through the acquisition of additional market-ready products.
For further insights into TSE:VPH stock, check out TipRanks’ Stock Analysis page.
